Alternatives to Envoya

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-driven digital twin of embryo development for cell-based therapies.

Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.

Cell and gene therapy company developing biological vehicles for CNS delivery.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

VI Therapeutics is developing novel therapies for rare genetic diseases.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.